Other Income & Expense

Unrealized Gain (Loss) on Investments

Amgen Unrealized Gain (Loss) on Investments decreased by 107.3% to -$143.00M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 111.0%, from $1.30B to -$143.00M. This is a positive signal — higher values indicate stronger performance for this metric.

Analysis

StatementIncome Statement
SectionOther Income & Expense
CategoryProfitability
SignalHigher is better
VolatilityVolatile
First reportedQ1 2021
Last reportedQ1 2026Apr 30, 2026

How to read this metric

Positive values indicate favorable market movements for held assets; negative values indicate market-driven declines in portfolio value.

Detailed definition

The change in the fair market value of investment securities that have not yet been sold, recognized directly in the inc...

Peer comparison

Standard for insurance companies reporting investment portfolio performance under fair value accounting.

Metric ID: amgn_unrealized_gain_loss_on_investments

Historical Data

16 periods
 Q2 '21Q3 '21Q4 '21Q1 '22Q2 '22Q4 '22Q1 '23Q3 '23Q4 '23Q1 '24Q2 '24Q3 '24Q4 '24Q1 '25Q3 '25Q1 '26
Value$0.00$0.00$0.00-$211.00M-$111.00M-$14.00M$1.83B$135.00M$261.00M-$515.00M-$401.00M$1.63B-$876.00M$1.30B$1.97B-$143.00M
QoQ Change+47.4%+87.4%>999%-92.6%+93.3%-297.3%+22.1%+507.2%-153.6%+247.8%+52.2%-107.3%
YoY Change+967.3%>999%-128.1%>999%-435.6%+351.5%+20.7%-111.0%
Range-$876.00M$1.97B
Avg YoY Growth+467.3%
Median YoY Growth+186.1%

Frequently Asked Questions

What is Amgen's unrealized gain (loss) on investments?
Amgen (AMGN) reported unrealized gain (loss) on investments of -$143.00M in Q1 2026.
How has Amgen's unrealized gain (loss) on investments changed year-over-year?
Amgen's unrealized gain (loss) on investments decreased by 111.0% year-over-year, from $1.30B to -$143.00M.
What does unrealized gain (loss) on investments mean?
Gains or losses on investments that have not yet been sold.